How much is Candesant Biomedical worth in 2026?

Candesant Biomedical has a current valuation of N/A based on their Accelerator/Incubator round and secondary market data.

How much funding has Candesant Biomedical raised?

Candesant Biomedical has raised N/A in total funding across 1 funding rounds.

Candesant Biomedical

Other Devices and Supplies

Candesant Biomedical valuation and funding history | Last updated: January 1, 2018 | 1 funding rounds

Current Valuation

N/A

As of January 1, 2018

Total Funding Raised

N/A

Across 1 round

Last Round

Accelerator/Incubator

Amount undisclosed

Last Funding

Jan 2018

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 1, 2018	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Candesant Biomedical is currently valued at N/A as of January 1, 2018.

Track Candesant Biomedical Valuation Updates

Get notified when Candesant Biomedical raises new funding or valuation changes

Explore More Data

Detailed analysis for Candesant Biomedical

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Candesant Biomedical's valuation history, funding rounds, and growth metrics.

No credit card required

What is Candesant Biomedical Worth in 2026?

Candesant Biomedical is a leading private company in the Other Devices and Supplies sector. Track Candesant Biomedical's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Candesant Biomedical Valuation is Determined

Private company valuations like Candesant Biomedical's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.